Petros Grivas, MD, PhD

No bio available.

Financial relationships

  • Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Genentech
    Date added:
    06/15/2024
    Date updated:
    02/28/2025
  • Type of financial relationship:
    Professional Services
    Ineligible company:
    MSD
    Date added:
    02/28/2025
    Date updated:
    02/28/2025
  • Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    MSD
    Date added:
    02/28/2025
    Date updated:
    02/28/2025
  • Type of financial relationship:
    Professional Services
    Ineligible company:
    Bicycle Therapeutics
    Date added:
    02/28/2025
    Date updated:
    02/28/2025
  • Type of financial relationship:
    Professional Services
    Ineligible company:
    Daiichi Sankyo
    Date added:
    02/28/2025
    Date updated:
    02/28/2025
  • Type of financial relationship:
    Professional Services
    Ineligible company:
    Replimune
    Date added:
    02/28/2025
    Date updated:
    02/28/2025
  • Type of financial relationship:
    Professional Services
    Ineligible company:
    Foundation Medicine
    Date added:
    02/28/2025
    Date updated:
    02/28/2025

Pages

Return to Recorded Webcast - Optimizing Immuno-Oncology: Innovations in Immune Checkpoint Inhibitor Delivery